13.37k followers • 11 symbols Watchlist by TREA
Follow this list to discover and track the stock of publicly traded companies with COVID-19 related treatment and healthcare plans.
Curated by TREA
|Watchlist||Change today||1-month return||1-year return||Total return|
|The Fight Against COVID19||+0.07%||-||-||-|
|Symbol||Company name||Last price||Change||% change||Market time||Volume||Avg vol (3-month)||Market cap|
|JNJ||Johnson & Johnson||148.53||+0.13||+0.09%||09:44 GMT-4||481.74k||6.89M||391.05B|
|PFE||Pfizer Inc.||38.7506||+0.30||+0.78%||09:44 GMT-4||2.70M||31.55M||215.25B|
|ABBV||AbbVie Inc.||93.4||+0.15||+0.16%||09:44 GMT-4||502.01k||9.27M||164.84B|
|GSK||GlaxoSmithKline plc||40.96||-0.25||-0.61%||09:44 GMT-4||237.79k||3.11M||102.51B|
|GILD||Gilead Sciences, Inc.||69.25||+0.25||+0.36%||09:44 GMT-4||1.04M||10.02M||86.87B|
|REGN||Regeneron Pharmaceuticals, Inc.||624.47||-0.05||-0.01%||09:44 GMT-4||59.26k||1.27M||64.07B|
|TAK||Takeda Pharmaceutical Company Limited||18.1991||-0.23||-1.25%||09:43 GMT-4||85.86k||1.14M||57.11B|
|BNTX||BioNTech SE||79.2705||-2.03||-2.50%||09:44 GMT-4||350.23k||2.92M||18.88B|
|NVAX||Novavax, Inc.||175||+1.51||+0.87%||09:44 GMT-4||852.14k||9.88M||10.27B|
|VIR||Vir Biotechnology, Inc.||52.09||+1.44||+2.84%||09:44 GMT-4||46.58k||1.47M||6.58B|
|INO||Inovio Pharmaceuticals, Inc.||21.0581||-0.73||-3.36%||09:44 GMT-4||2.19M||35.64M||3.33B|
GSK's belantamab mafodotin, or BLENREP, was approved for treating adults with relapsed and refractory multiple myeloma who no longer respond to treatment with an immunomodulatory agent, the drugmaker said in a statement. Multiple myeloma is the second most common form of blood cancer in the U.S. and is generally considered treatable, but not curable. A U.S. FDA panel had earlier raised safety concerns about the drug causing deposits to gather on the cornea in the eyes, but later voted in its favor saying the benefits of the treatment outweigh the risks.
FDA Approves GSK’s BLENREP (belantamab mafodotin-blmf) for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma.
By Gina Lee